US Stock MarketDetailed Quotes

C4 Therapeutics (CCCC)

Watchlist

3.680
+0.510+16.09%

Close May 13 16:00 ET

3.701
+0.021+0.58%

Pre 06:48 ET

406.89MMarket Cap-3.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

C4 Therapeutics (CCCC) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

10.04%-29.94M

-51.47%-98.69M

-23.49%-22.15M

-29.31%-31.21M

-142.40%-12.06M

-83.71%-33.29M

39.01%-65.16M

25.31%-17.93M

21.41%-24.13M

73.82%-4.97M

Net income from continuing operations

4.53%-25.13M

0.31%-104.99M

40.75%-20.49M

-30.41%-32.17M

-46.87%-26.02M

7.19%-26.32M

20.51%-105.32M

0.52%-34.57M

8.77%-24.67M

50.68%-17.72M

Depreciation and amortization

-11.40%404K

7.76%1.96M

-10.83%428K

4.07%460K

37.28%615K

1.79%456K

-3.30%1.82M

11.63%480K

-1.12%442K

-2.18%448K

Other non cash items

15.38%30K

1,550.00%99K

144.68%21K

-3.23%30K

-80.53%22K

128.57%26K

-98.76%6K

-9.30%-47K

-69.90%31K

-47.20%113K

Change In working capital

40.14%-8.27M

-482.87%-29.28M

-190.00%-6.68M

-78.11%-16.03M

23.50%7.25M

-511.62%-13.82M

210.23%7.65M

118.13%7.42M

33.31%-9M

-37.41%5.87M

-Change in receivables

90.22%-482K

-91.94%701K

-42.80%4.14M

52.68%-4.34M

-53.13%5.83M

-173.82%-4.93M

184.22%8.7M

164.06%7.24M

-1,837.50%-9.17M

2,586.20%12.43M

-Change in prepaid assets

-64.22%122K

126.43%1.14M

-7,964.29%-2.26M

-170.10%-572K

914.57%3.63M

107.30%341K

-258.94%-4.33M

-102.12%-28K

217.92%816K

-127.91%-446K

-Change in payables and accrued expense

51.09%-3.61M

-370.20%-6.52M

-57.96%1.6M

-160.90%-2.9M

187.63%2.16M

1.42%-7.38M

-187.22%-1.39M

-29.00%3.8M

403.31%4.76M

-252.60%-2.47M

-Change in other current liabilities

-10.42%-1.54M

-10.63%-5.77M

-10.61%-1.48M

-10.60%-1.46M

-10.58%-1.44M

-10.75%-1.39M

-11.16%-5.22M

-10.95%-1.34M

-11.01%-1.32M

-10.98%-1.3M

-Change in other working capital

-492.93%-2.77M

-290.57%-18.84M

-285.99%-8.68M

-65.47%-6.76M

-24.93%-2.93M

-102.52%-467K

162.04%9.88M

-124.34%-2.25M

61.38%-4.08M

-129.95%-2.35M

Cash from discontinued investing activities

Operating cash flow

10.04%-29.94M

-51.47%-98.69M

-23.49%-22.15M

-29.31%-31.21M

-142.40%-12.06M

-83.71%-33.29M

39.01%-65.16M

25.31%-17.93M

21.41%-24.13M

73.82%-4.97M

Investing cash flow

Cash flow from continuing investing activities

-44.54%16.15M

83.22%-8.6M

-690.59%-80.73M

2,422.22%4.09M

432.49%38.92M

154.55%29.13M

-132.38%-51.27M

-57.21%13.67M

-99.72%162K

-177.28%-11.71M

Net PPE purchase and sale

---64K

-237.22%-607K

-375.00%-11K

-3,261.54%-411K

6.09%-185K

--0

89.46%-180K

102.55%4K

102.17%13K

45.58%-197K

Net investment purchase and sale

-44.32%16.22M

84.35%-7.99M

-690.68%-80.72M

2,918.12%4.5M

439.79%39.11M

154.55%29.13M

-131.92%-51.09M

-57.43%13.67M

-99.74%149K

-174.20%-11.51M

Cash from discontinued investing activities

Investing cash flow

-44.54%16.15M

83.22%-8.6M

-690.59%-80.73M

2,422.22%4.09M

432.49%38.92M

154.55%29.13M

-132.38%-51.27M

-57.21%13.67M

-99.72%162K

-177.28%-11.71M

Financing cash flow

Cash flow from continuing financing activities

1,104.35%462K

178.80%126.4M

105,857.14%118.67M

-26.01%7.77M

-100.13%-46K

-0.34%45.34M

-99.81%112K

197.70%10.51M

118.10%135K

Net issuance payments of debt

----

--0

Net common stock issuance

-29.03%-200K

185.26%126.02M

--118.67M

-26.42%7.5M

--0

-100.46%-155K

-23.26%44.18M

--0

63,825.00%10.2M

--0

Proceeds from stock option exercised by employees

--606K

-86.25%107K

--0

723.08%107K

--0

1,241.38%778K

--111K

--13K

6,650.00%135K

Net other financing activities

-48.62%56K

-28.27%274K

0.00%1K

-44.78%164K

--0

29.76%109K

3.80%382K

200.00%1K

12.93%297K

--0

Cash from discontinued financing activities

Financing cash flow

1,104.35%462K

178.80%126.4M

105,857.14%118.67M

-26.01%7.77M

--0

-100.13%-46K

-0.34%45.34M

-99.81%112K

197.70%10.51M

118.10%135K

Net cash flow

Beginning cash position

32.41%78.05M

-54.67%58.94M

-1.33%62.25M

6.59%81.6M

-41.21%54.74M

-54.67%58.94M

293.65%130.03M

-2.07%63.09M

58.96%76.56M

76.48%93.1M

Current changes in cash

-216.90%-13.33M

126.87%19.1M

480.58%15.79M

-43.69%-19.35M

262.37%26.86M

88.61%-4.21M

-173.29%-71.09M

-106.33%-4.15M

-182.79%-13.47M

-260.07%-16.55M

End cash Position

18.23%64.72M

32.41%78.05M

-1.33%62.25M

6.59%81.6M

-41.21%54.74M

-54.67%58.94M

-2.07%63.09M

58.96%76.56M

Free cash flow

9.85%-30.01M

-51.98%-99.3M

-23.58%-22.16M

-31.09%-31.62M

-136.74%-12.24M

-83.71%-33.29M

39.81%-65.34M

25.81%-17.93M

22.96%-24.12M

73.29%-5.17M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	10.04%-29.94M	-51.47%-98.69M	-23.49%-22.15M	-29.31%-31.21M	-142.40%-12.06M	-83.71%-33.29M	39.01%-65.16M	25.31%-17.93M	21.41%-24.13M	73.82%-4.97M
Net income from continuing operations	4.53%-25.13M	0.31%-104.99M	40.75%-20.49M	-30.41%-32.17M	-46.87%-26.02M	7.19%-26.32M	20.51%-105.32M	0.52%-34.57M	8.77%-24.67M	50.68%-17.72M
Depreciation and amortization	-11.40%404K	7.76%1.96M	-10.83%428K	4.07%460K	37.28%615K	1.79%456K	-3.30%1.82M	11.63%480K	-1.12%442K	-2.18%448K
Other non cash items	15.38%30K	1,550.00%99K	144.68%21K	-3.23%30K	-80.53%22K	128.57%26K	-98.76%6K	-9.30%-47K	-69.90%31K	-47.20%113K
Change In working capital	40.14%-8.27M	-482.87%-29.28M	-190.00%-6.68M	-78.11%-16.03M	23.50%7.25M	-511.62%-13.82M	210.23%7.65M	118.13%7.42M	33.31%-9M	-37.41%5.87M
-Change in receivables	90.22%-482K	-91.94%701K	-42.80%4.14M	52.68%-4.34M	-53.13%5.83M	-173.82%-4.93M	184.22%8.7M	164.06%7.24M	-1,837.50%-9.17M	2,586.20%12.43M
-Change in prepaid assets	-64.22%122K	126.43%1.14M	-7,964.29%-2.26M	-170.10%-572K	914.57%3.63M	107.30%341K	-258.94%-4.33M	-102.12%-28K	217.92%816K	-127.91%-446K
-Change in payables and accrued expense	51.09%-3.61M	-370.20%-6.52M	-57.96%1.6M	-160.90%-2.9M	187.63%2.16M	1.42%-7.38M	-187.22%-1.39M	-29.00%3.8M	403.31%4.76M	-252.60%-2.47M
-Change in other current liabilities	-10.42%-1.54M	-10.63%-5.77M	-10.61%-1.48M	-10.60%-1.46M	-10.58%-1.44M	-10.75%-1.39M	-11.16%-5.22M	-10.95%-1.34M	-11.01%-1.32M	-10.98%-1.3M
-Change in other working capital	-492.93%-2.77M	-290.57%-18.84M	-285.99%-8.68M	-65.47%-6.76M	-24.93%-2.93M	-102.52%-467K	162.04%9.88M	-124.34%-2.25M	61.38%-4.08M	-129.95%-2.35M
Cash from discontinued investing activities
Operating cash flow	10.04%-29.94M	-51.47%-98.69M	-23.49%-22.15M	-29.31%-31.21M	-142.40%-12.06M	-83.71%-33.29M	39.01%-65.16M	25.31%-17.93M	21.41%-24.13M	73.82%-4.97M
Investing cash flow
Cash flow from continuing investing activities	-44.54%16.15M	83.22%-8.6M	-690.59%-80.73M	2,422.22%4.09M	432.49%38.92M	154.55%29.13M	-132.38%-51.27M	-57.21%13.67M	-99.72%162K	-177.28%-11.71M
Net PPE purchase and sale	---64K	-237.22%-607K	-375.00%-11K	-3,261.54%-411K	6.09%-185K	--0	89.46%-180K	102.55%4K	102.17%13K	45.58%-197K
Net investment purchase and sale	-44.32%16.22M	84.35%-7.99M	-690.68%-80.72M	2,918.12%4.5M	439.79%39.11M	154.55%29.13M	-131.92%-51.09M	-57.43%13.67M	-99.74%149K	-174.20%-11.51M
Cash from discontinued investing activities
Investing cash flow	-44.54%16.15M	83.22%-8.6M	-690.59%-80.73M	2,422.22%4.09M	432.49%38.92M	154.55%29.13M	-132.38%-51.27M	-57.21%13.67M	-99.72%162K	-177.28%-11.71M
Financing cash flow
Cash flow from continuing financing activities	1,104.35%462K	178.80%126.4M	105,857.14%118.67M	-26.01%7.77M	0	-100.13%-46K	-0.34%45.34M	-99.81%112K	197.70%10.51M	118.10%135K
Net issuance payments of debt	----	----	----	----	----	----	--0	--0	--0	--0
Net common stock issuance	-29.03%-200K	185.26%126.02M	--118.67M	-26.42%7.5M	--0	-100.46%-155K	-23.26%44.18M	--0	63,825.00%10.2M	--0
Proceeds from stock option exercised by employees	--606K	-86.25%107K	--0	723.08%107K	--0	--0	1,241.38%778K	--111K	--13K	6,650.00%135K
Net other financing activities	-48.62%56K	-28.27%274K	0.00%1K	-44.78%164K	--0	29.76%109K	3.80%382K	200.00%1K	12.93%297K	--0
Cash from discontinued financing activities
Financing cash flow	1,104.35%462K	178.80%126.4M	105,857.14%118.67M	-26.01%7.77M	--0	-100.13%-46K	-0.34%45.34M	-99.81%112K	197.70%10.51M	118.10%135K
Net cash flow
Beginning cash position	32.41%78.05M	-54.67%58.94M	-1.33%62.25M	6.59%81.6M	-41.21%54.74M	-54.67%58.94M	293.65%130.03M	-2.07%63.09M	58.96%76.56M	76.48%93.1M
Current changes in cash	-216.90%-13.33M	126.87%19.1M	480.58%15.79M	-43.69%-19.35M	262.37%26.86M	88.61%-4.21M	-173.29%-71.09M	-106.33%-4.15M	-182.79%-13.47M	-260.07%-16.55M
End cash Position	18.23%64.72M	32.41%78.05M	32.41%78.05M	-1.33%62.25M	6.59%81.6M	-41.21%54.74M	-54.67%58.94M	-54.67%58.94M	-2.07%63.09M	58.96%76.56M
Free cash flow	9.85%-30.01M	-51.98%-99.3M	-23.58%-22.16M	-31.09%-31.62M	-136.74%-12.24M	-83.71%-33.29M	39.81%-65.34M	25.81%-17.93M	22.96%-24.12M	73.29%-5.17M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm